carbamylhydrazine has been researched along with Leishmaniasis, Visceral in 1 studies
carbamylhydrazine: RN given refers to parent cpd
Leishmaniasis, Visceral: A chronic disease caused by LEISHMANIA DONOVANI and transmitted by the bite of several sandflies of the genera Phlebotomus and Lutzomyia. It is commonly characterized by fever, chills, vomiting, anemia, hepatosplenomegaly, leukopenia, hypergammaglobulinemia, emaciation, and an earth-gray color of the skin. The disease is classified into three main types according to geographic distribution: Indian, Mediterranean (or infantile), and African.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Evans, AT | 1 |
| Croft, SL | 1 |
| Peters, W | 1 |
| Neal, RA | 1 |
1 other study available for carbamylhydrazine and Leishmaniasis, Visceral
| Article | Year |
|---|---|
Hydrazide antidepressants possess novel antileishmanial activity in vitro and in vivo.
Topics: Animals; Carbidopa; Drug Evaluation, Preclinical; Drug Interactions; Leishmania donovani; Leishmania | 1989 |